Tandem widens recall
February 17, 2014
Tandem Diabetes Care in the US
has expanded its voluntary recall
of insulin cartridges used with the
t:slim Insulin Pump, the US Food
and Drug Administration (FDA) said.
The cartridges could be at risk
of leaking, potentially resulting in
delivering too much or too little
insulin.
The affected lots represent
roughly 13,000 boxes of cartridges
at 10 cartridges per box, or 130,000
cartridges in total.
Previously the company reported
that about 4,746 boxes, or 47,460
cartridges, had been affected (PD
10 Feb).
Tandem ceo Kim Blickenstaff
said testing continued after
the company’s previous
announcement, with the result that
further cartridge lots were thought
to be possibly at risk.
To view lot numbers, CLICK HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 17 Feb 14To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Feb 14
